Concepedia

FasL gene therapy: a new therapeutic modality for head and neck cancer

Saeed Elojeimy, John McKillop, Ahmed El‐Zawahry, David H. Holman, X Liu, David A. Schwartz, Thomas A. Day, J-Y Dong, James S. Norris

Cancer Gene Therapy · 2006 · 38 citations · 15 references

DOI

Concepts

References

15

Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor family

Takashi Suda, Tomohiro Takahashi, Pierre Golstein et al. · Cell · 1993 · 2.5K citations

, , +17

Trends in incidence and prognosis for head and neck cancer in the United States: A site‐specific analysis of the SEER database

André Lopes Carvalho, Inês Nobuko Nishimoto, Joseph A. Califano et al. · International Journal of Cancer · 2004 · 861 citations · Full text

, , +11

Purification and characterization of the Fas-ligand that induces apoptosis.

Toshio Suda, Shigekazu Nagata · The Journal of Experimental Medicine · 1994 · 517 citations · Full text

, , +17

Membrane Fas Ligand Kills Human Peripheral Blood T Lymphocytes, and Soluble Fas Ligand Blocks the Killing

Takashi Suda, Hideo Hashimoto, Masato Tanaka et al. · The Journal of Experimental Medicine · 1997 · 509 citations · Full text

, , +14

Human Fas ligand: gene structure, chromosomal location and species specificity

Tomohiro Takahashi, Masato Tanaka, Johji Inazawa et al. · International Immunology · 1994 · 432 citations

, , +8